Company / Working Capital per Share
PLIANT THERAPEUTICS, INC. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.96
FY2025
5-year range
$2.96 / $9.75
FY2021-FY2025
Trend
-46.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $9.75 to $2.96 over the past 2 years.
Based on SEC 10-K filings.
2.96 in FY2025 with a 5-year CAGR of -54.5%.
Declined from $9.75 to $2.96 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -30.4%
- 5-Year CAGR
- -54.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share decreased 46.1% year-over-year.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.96 | -46.1% |
| FY2024 | $5.49 | -43.7% |
| FY2023 | $9.75 | +11.1% |
| FY2022 | $8.77 | +61.9% |
| FY2021 | $5.42 | -96.4% |
| FY2020 | $151.22 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026